Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 5446
  • 5447
  • 5448
  • …
  • ›
  • »

2026-04-08

Is Lancaster Colony a Hidden Gem Dividend King? The Bull and Bear Cases

2026-04-08

Osisko Gold Royalties reports Q1 data

2026-04-08

KB4-CON 2026 to Feature World-Renowned Climber Alex Honnold and Documentary Filmmaker Brett Culp as Keynote Speakers

2026-04-08

Glaukos to Release First Quarter 2026 Financial Results after Market Close on April 29

2026-04-08

New Jersey Resources Schedules Fiscal 2026 Second Quarter Earnings Call

2026-04-08

Henry Schein to Reduce Size of the Board of Directors following 2026 Annual Meeting of Stockholders

2026-04-08

Sidewinder Therapeutics Announces $137 Million Series B Financing to Advance Precision Bispecific ADCs into Clinical Development for Cancer

2026-04-08

Kooth says annual earnings down but highlights ′strong execution′

2026-04-08

Motorpoint hails ′record′ retail volumes as profit jumps

2026-04-08

FactSet Announces Chief Financial Officer Transition

2026-04-08

OR Royalties Announces Preliminary Q1 2026 GEO Deliveries and C$17.7 Million of Share Repurchases Under the Normal Course Issuer Bid 

2026-04-08

iBio Received Regulatory Clearance to Initiate Its Phase 1 Clinical Trial of IBIO-600 in Australia

  • «
  • ‹
  • …
  • 5446
  • 5447
  • 5448
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies